- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00541060
Study of Factors of Genetic Susceptibility Associated to Severe Caries Phenotype (Cariogene)
December 17, 2010 updated by: Assistance Publique - Hôpitaux de Paris
Study of Factors of Genetic Susceptibility Associated to Severe Caries Phenotype in Young Patients. First Approach by Systematic Screening of Candidate Genes
Alteration of the post- eruptive enamel microstructure due to a mutation of a gene coding for a matrix protein could increase the susceptibility of the enamel to caries after tooth eruption.
To identify in young patients with severe caries incidence, the occurrence of mutations in several candidate genes which result in an alteration of the enamel microstructure that could explain the high caries susceptibility of the patient.
Study Overview
Detailed Description
Although its prevalence has decreased dramatically in European countries, dental caries remains a burden for the society and especially for certain groups of the population.
For example, 80% of the carious lesions are diagnosed in about 20% of the children.
For years, the aetiology of this disease has been mainly related to environmental factors but recent data support the possibility of a human genetic contribution.
Alteration of the post- eruptive enamel microstructure due to a mutation of a gene coding for a matrix protein could increase the susceptibility of the enamel to caries after tooth eruption.
The main objective of this study will be to identify in young patients with severe caries incidence, the occurrence of mutations in several candidate genes which result in an alteration of the enamel microstructure that could explain the high caries susceptibility of the patient.
With this aim, we will carry out a case- control multicentre European study on 250 young patients presenting several carious lesions and 160 young adults totally caries free.
Patients with systemic or enamel pathologies such as amelogenesis imperfecta will not be included in the study.
The study will consist of 2 visits, 1: inclusion and genetic test based on a salivary sample and 2: after 6 months, communication of the genetic test result to the patient and his parents.
The main evaluation criteria will be the finding of a mutation on the candidates genes not resulting in an amelogenesis imperfecta phenotype but associated to a severe caries phenotype.
If a direct relation between a mutation and a severe caries phenotype was shown, all the classical approaches, prevention protocols and treatments of caries would need to be reconsidered.
Study Type
Interventional
Enrollment (Actual)
390
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Paris, France, 75018
- Hôpital Bretonneau
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 30 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients : presenting at least 3 active carious lesions aged 2 to 16 years old, written informed consent
- Volunteers : young adults 18 to 30 years old totally caries free
Exclusion Criteria:
- patients with systemic or enamel pathologies such as amelogenesis imperfecta
- osteogenesis imperfecta
- hypophosphatemia
- hypodermal dysplasia
- syndrome of Prader Willi
- Fluoroses
- toxic enamel dysplasia
- pregnancy or breast-feeding
- HYPOSIALORRHEA
- immunodepression status
- chronicle diseases
- anorexia or bulimia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: A
250 young patients presenting several carious lesions
|
a mutation of a gene coding
Other Names:
|
Placebo Comparator: B
160 young adults totally caries free
|
a mutation of a gene coding
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the finding of a mutation on the candidates genes not resulting in an amelogenesis imperfecta phenotype but associated to a severe caries phenotype
Time Frame: baseline, 6 months
|
baseline, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
If a direct relation between a mutation and a severe caries phenotype was shown, all the classical approaches, prevention protocols and treatments of caries would need to be reconsidered.
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Catherine Miller, MCU-PH, Assistance Publique - Hôpitaux de Paris
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2007
Primary Completion (Actual)
November 1, 2009
Study Completion (Actual)
November 1, 2009
Study Registration Dates
First Submitted
October 4, 2007
First Submitted That Met QC Criteria
October 4, 2007
First Posted (Estimate)
October 8, 2007
Study Record Updates
Last Update Posted (Estimate)
December 20, 2010
Last Update Submitted That Met QC Criteria
December 17, 2010
Last Verified
November 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P061009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Caries
-
Ain Shams UniversityCompletedPulpitis | Caries | Caries,Dental | Reversible Pulpitis | Caries Class I | Caries; DentinEgypt
-
University of MinnesotaCompletedUsing Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood CariesCaries | Caries,DentalUnited States
-
National University of San Marcos, PeruNot yet recruitingPit and Fissure Caries | Caries,Dental | Sealant DentalPeru
-
3MUniversity of MichiganActive, not recruiting
-
Hue University of Medicine and PharmacyRecruitingOcclusal Caries | Caries,Dental | Caries; InitialVietnam
-
Rawda Hesham Abd ElAzizRecruitingCaries,Dental | Caries Class IIEgypt
-
The University of Texas Health Science Center,...National Institute of Dental and Craniofacial Research (NIDCR)RecruitingCaries,DentalUnited States
-
Federal University of PelotasRecruiting
-
Kompetansesenteret Tannhelse Midt (TkMidt)Karolinska Institutet; University of Bergen; Norwegian University of Science... and other collaboratorsActive, not recruiting
-
Marmara UniversityCompleted
Clinical Trials on mutation
-
Fudan UniversityUnknown
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedKidney Cancer | Von Hippel-lindau SyndromeUnited States
-
Seoul National University Bundang HospitalCompletedColorectal CancerKorea, Republic of
-
Sun Yat-sen UniversityEnrolling by invitation
-
Centre Hospitalier Universitaire de BesanconCompletedBreast Cancer | BRCA1 Mutation | BRCA2 MutationFrance
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Completed
-
Dr Cipto Mangunkusumo General HospitalCompletedColorectal Cancer | APC Gene Mutation | TP53 Gene Mutation | PIK3CA Gene Mutation | KRAS Mutation-Related Tumors | MLH1 Gene MutationIndonesia
-
Shanghai Zhongshan HospitalUnknownPortal Hypertension | Myeloproliferative Neoplasm | Gastroesophageal Varices | Portal Caver CavernomaChina
-
PediatrixCompletedJaundice | HyperbilirubinemiaUnited States
-
DermTechRecruitingPhotoagingUnited States